The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?
Abstract Objective: Lower urinary tract symptoms (LUTS), which are related to benign prostate hyperplasia (BPH), are the most commonly encountered diseases in urological practice. In our study, we compared responses to doxazosin mesylate extended release tablets (doxazosin XL) (8 mg) treatment betw...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Turkish Association of Urology
2019-07-01
|
| シリーズ: | Urology Research and Practice |
| 主題: | |
| オンライン･アクセス: | http://urologyresearchandpractice.org/index.php/pub/article/view/2764 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|